Issue Date: April 13, 2018
Volume 45 • Issue 8 • Page 427
MARYLAND DEPARTMENT OF HEALTH
Subtitle 09 MEDICAL CARE PROGRAMS
10.09.09 Medical Laboratories
Authority: Health-General Article, §§2-104(b) 15-103, and 15-105, Annotated Code of Maryland
Notice of Proposed Action
The Secretary of Health proposes to amend Regulation .03 under COMAR 10.09.09 Medical Laboratories.
Statement of Purpose
The purpose of this action is to correct an outdated COMAR citation.
Comparison to Federal Standards
There is no corresponding federal standard to this proposed action.
Estimate of Economic Impact
The proposed action has no economic impact.
Economic Impact on Small Businesses
The proposed action has minimal or no economic impact on small businesses.
Impact on Individuals with Disabilities
The proposed action has no impact on individuals with disabilities.
Opportunity for Public Comment
Comments may be sent to Michele Phinney, Director, Office of Regulation and Policy Coordination, Maryland Department of Health, 201 West Preston Street, Room 512, Baltimore, MD 21201, or call 410-767-6499 (TTY 800-735-2258), or email to email@example.com, or fax to 410-767-6483. Comments will be accepted through May 14, 2018. A public hearing has not been scheduled.
.03 Conditions for Participation.
A. General requirements for participation in the Program are that a provider shall meet all conditions for participation as set forth in COMAR 10.09.36.03, except that a signature on the services order specified in COMAR [10.09.36.03A(15)] 10.09.36.03A(19) is not required.
B. (text unchanged)
ROBERT R. NEALL
Secretary of Health